Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression

Cancer Research

Volumn 71, Issue 9, 2011, Pages 3236-3245

  Hilvo, Mika ^a   Denkert, Carsten ^b   Lehtinen, Laura ^a   Müller, Berit ^b   Brockmöller, Scarlet ^b   Seppänen Laakso, Tuulikki ^a   Budczies, Jan ^b   Bucher, Elmar ^a   Yetukuri, Laxman ^a   Castillo, Sandra ^a   Berg, Emilia ^a   Nygren, Heli ^a   Sysi Aho, Marko ^a   Griffin, Julian L ^e   Fiehn, Oliver ^f   Loibl, Sibylle ^g   Richter Ehrenstein, Christiane ^c   Radke, Cornelia ^d   Hyötyläinen, Tuulia ^a   Kallioniemi, Olli ^a   Iljin, Kristiina ^a   Orešič, Matej ^a   more..

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b Institute of Pathology   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d DRK Hospital Berlin Köpenick Salvador   (Germany)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g GBG Forschungs GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MEMBRANE PHOSPHOLIPID; PALMITIC ACID; PHOSPHATIDYLCHOLINE;

ACACA GENE; ARTICLE; BREAST CANCER; CANCER GROWTH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; ELOVL1 GENE; FASN GENE; FATTY ACID SYNTHESIS; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSIG1 GENE; LIPID ANALYSIS; LIPID METABOLISM; LIPIDOMICS; MASS SPECTROMETRY; METABOLIC REGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAP GENE; SCD GENE; SURVIVAL; THRSP GENE; TRANSCRIPTOMICS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; DISEASE PROGRESSION; FATTY ACID SYNTHETASE COMPLEX; FEMALE; GENE EXPRESSION PROFILING; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; PHOSPHOLIPIDS; RECEPTORS, ESTROGEN; RNA, MESSENGER; SURVIVAL RATE;

EID: 79955518028     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-3894     Document Type: Article

References (35)

1. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007;7:763-77. (Pubitemid 47469806)
2. Hirsch HA, Iliopoulos D, Joshi A, Zhang Y, Jaeger SA, Bulyk M, et al. A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 2010;17:348-61.
3. Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY, et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res 2008;68:1003-11. (Pubitemid 351278386)
4. Swinnen JV, Roskams T, Joniau S, Van Poppel H, Oyen R, Baert L, et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 2002;98:19-22. (Pubitemid 34113412)
5. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A 1994;91:6379-83. (Pubitemid 24200664)
6. Chajes V, Lanson M, Fetissof F, Lhuillery C, Bougnoux P. Membrane fatty acids of breast carcinoma: contribution of host fatty acids and tumor properties. Int J Cancer 1995;63:169-75.
7. Kuhajda FP. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 2006;66:5977-80.
8. Milgraum LZ, Witters LA, Pasternack GR, Kuhajda FP. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res 1997;3:2115-20. (Pubitemid 27505140)
9. Swinnen JV, Vanderhoydonc F, Elgamal AA, Eelen M, Vercaeren I, Joniau S, et al. Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int J Cancer 2000;88:176-9.
10. Oresic M, Hanninen VA, Vidal-Puig A. Lipidomics: a new window to biomedical frontiers. Trends Biotechnol 2008;26:647-52.
11. Han X, Gross RW. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res 2003;44:1071-9. (Pubitemid 37279625)
12. Lagarde M, Geloen A, Record M, Vance D, Spener F. Lipidomics is emerging. Biochim Biophys Acta 2003;1634:61. (Pubitemid 37487709)
13. Pluskal T, Castillo S, Villar-Briones A, Oresic M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry- based molecular profile data. BMC Bioinformatics 2010;11:395.
14. Kilpinen S, Autio R, Ojala K, Iljin K, Bucher E, Sara H, et al. Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol 2008;9:R139.
15. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987;8:138-40.
16. Bylesjo M, Rantalainen M, Nicholson JK, Holmes E, Trygg J. K-OPLS package: kernel-based orthogonal projections to latent structures for prediction and interpretation in feature space. BMC Bioinformatics 2008;9:106.
17. Fisher ER, Osborne CK, McGuire WL, Redmond C, Knight WA III, Fisher B, et al. Correlation of primary breast cancer histopathology and estrogen receptor content. Breast Cancer Res Treat 1981;1:37-41. (Pubitemid 12179413)
18. Smith S.The animal fatty acid synthase: one gene, one polypeptide, seven enzymes. FASEB J 1994;8:1248-59.
19. Cook HW, McMaster CR. Fatty acid desaturation and chain elongation in eukaryotes. In:Vance DE, Vance JE, editors. Biochemistry of Lipids, Lipoproteins and Membranes. 4th ed. Amsterdam, the Netherlands: Elsevier B V; 2002. p. 181-204.
20. Ollila S, Hyvonen MT, Vattulainen I. Polyunsaturation in lipid membranes: dynamic properties and lateral pressure profiles. J Phys Chem B 2007;111:3139-50. (Pubitemid 46573461)
21. Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S, et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res 2010;70:8117-26.
22. Jakobsson A, Westerberg R, Jacobsson A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 2006;45:237-49.
23. Moore S, Knudsen B, True LD, Hawley S, Etzioni R, Wade C, et al. Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma. Int J Cancer 2005;114:563-71. (Pubitemid 40349614)
24. Falvella FS, Pascale RM, Gariboldi M, Manenti G, De Miglio MR, Simile MM, et al. Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats. Carcinogenesis 2002;23:1933-6. (Pubitemid 35355943)
25. Scaglia N, Igal RA. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis. Int J Oncol 2008;33:839-50.
26. Scaglia N, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase- 1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PLoS One 2009;4:e6812.
27. Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 2003;63:132-9. (Pubitemid 36070431)
28. Swinnen JV, Heemers H, Deboel L, Foufelle F, Heyns W, Verhoeven G. Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene 2000;19:5173-81.
29. Van de Sande T, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV. Role of the phosphatidylinositol 30-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Cancer Res 2002;62:642-6. (Pubitemid 34126933)
30. Menendez JA, Vellon L, Mehmi I, Oza BP, Ropero S, Colomer R, et al. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc Natl Acad Sci U S A 2004;101:10715-20. (Pubitemid 38955808)
31. Yoon S, Lee MY, Park SW, Moon JS, Koh YK, Ahn YH, et al. Upregulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. J Biol Chem 2007;282:26122-31. (Pubitemid 47443806)
32. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A 2003;100:12027-32. (Pubitemid 37271509)
33. Engelking LJ, Kuriyama H, Hammer RE, Horton JD, Brown MS, Goldstein JL, et al. Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J Clin Invest 2004;113:1168-75. (Pubitemid 38544102)
34. Medes G, Thomas A, Weinhouse S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res 1953;13:27-9.
35. METAcancer EU FP7 Collaborative project web site[cited 2011 Mar 4]. Available from: http://www.metacancer-fp7.eu.